{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:20:48Z","timestamp":1771456848836,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,7,9]],"date-time":"2007-07-09T00:00:00Z","timestamp":1183939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s11936-007-0026-1","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T02:58:49Z","timestamp":1184641129000},"page":"310-317","source":"Crossref","is-referenced-by-count":6,"title":["Thromboembolic risk in the patient with heart failure"],"prefix":"10.1007","volume":"9","author":[{"given":"Liviu","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,9]]},"reference":[{"key":"26_CR1","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","volume":"115","author":"W. Rosamond","year":"2007","unstructured":"Rosamond W, Flegal K, Friday G, et al.: Heart disease and stroke statistics-2007 Update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69\u2013e171.","journal-title":"Circulation"},{"key":"26_CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/eurheartj\/14.2.205","volume":"14","author":"S.M. Jafri","year":"1993","unstructured":"Jafri SM, Ozawa T, Mammen E, et al.: Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J 1993, 14:205\u2013212.","journal-title":"Eur Heart J"},{"key":"26_CR3","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/0735-1097(95)00049-A","volume":"25","author":"K. Yamamoto","year":"1995","unstructured":"Yamamoto K, Ikeda U, Furuhashi K, et al.: The coagulation system is activated in idiopathic cardiomyopathy. J Am Coll Cardiol 1995, 25:1634\u20131640.","journal-title":"J Am Coll Cardiol"},{"key":"26_CR4","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0735-1097(99)00033-9","volume":"33","author":"G.Y.H. Lip","year":"1999","unstructured":"Lip GYH, Gibbs CR: Does heart failure confer a hypercoagulable state? J Am Coll Cardiol 1999, 33:1424\u20131426.","journal-title":"J Am Coll Cardiol"},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/01.CIR.0000153349.77489.CF","volume":"111","author":"S.D. Katz","year":"2005","unstructured":"Katz SD, Hryniewicz K, Hriljac I, et al.: Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005, 111:310\u2013314.","journal-title":"Circulation"},{"key":"26_CR6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/003693308102600205","volume":"26","author":"J.J. Belch","year":"1981","unstructured":"Belch JJ, Lowe GD, Ward AG, et al.: Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 1981, 26:115\u2013117.","journal-title":"Scott Med J"},{"key":"26_CR7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","volume":"341","author":"M.M. Samama","year":"1999","unstructured":"Samama MM, Cohen AT, Darmon JY, et al.: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999, 341:793\u2013800.","journal-title":"N Engl J Med"},{"key":"26_CR8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archinte.164.9.963","volume":"164","author":"R. Alikhan","year":"2004","unstructured":"Alikhan R, Cohen AT, Combe S, et al.: Risk factors for venous thromboembolism in hospitalized patients with acute medical illness. Analysis of the MEDENOX study. Arch Intern Med 2004, 164:963\u2013968.","journal-title":"Arch Intern Med"},{"key":"26_CR9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.amjcard.2006.03.064","volume":"98","author":"A. Beemath","year":"2006","unstructured":"Beemath A, Stein PD, Skaf E, et al.: Risk of venous thromboembolism in patients hospitalized with heart failure. Am J Cardiol 2006, 98:793\u2013795.","journal-title":"Am J Cardiol"},{"key":"26_CR10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.amjcard.2006.05.030","volume":"98","author":"A. Beemath","year":"2006","unstructured":"Beemath A, Skaf E, Stein PD: Pulmonary embolism as a cause of death in adults who died with heart failure. Am J Cardiol 2006, 98:1073\u20131075.","journal-title":"Am J Cardiol"},{"key":"26_CR11","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1378\/chest.128.4.2576","volume":"128","author":"E.S. Darze","year":"2005","unstructured":"Darze ES, Latado AL, Guimaraes AG, et al.: Incidence and clinical predictors of pulmonary embolism in severe heart failure patients admitted to a coronary care unit. Chest 2005, 128:2576\u20132580.","journal-title":"Chest"},{"key":"26_CR12","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/eurheartj\/ehi130","volume":"26","author":"M. Ogren","year":"2005","unstructured":"Ogren M, Bergqvist D, Eriksson H, et al.: Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsies. Eur Heart J 2005, 26:1108\u20131114.","journal-title":"Eur Heart J"},{"key":"26_CR13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9149(81)90534-8","volume":"47","author":"V. Fuster","year":"1981","unstructured":"Fuster V, Gersh BJ, Giuliani ER, et al.: The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981, 47:525\u2013531.","journal-title":"Am J Cardiol"},{"key":"26_CR14","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0002-9149(83)90588-X","volume":"52","author":"J.S. Gottdiener","year":"1983","unstructured":"Gottdiener JS, Gay JA, Van Voorhees L, et al.: Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy. Assessment by 2-dimensional echocardiography. Am J Cardiol 1983, 52:1281\u20131285.","journal-title":"Am J Cardiol"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/hrt.58.4.393","volume":"58","author":"R.A. Diaz","year":"1987","unstructured":"Diaz RA, Obasohan A, Oakley CM: Prediction of outcome in dilated cardiomyopathy. Br Heart J 1987, 58:393\u2013399.","journal-title":"Br Heart J"},{"key":"26_CR16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/hrt.62.1.26","volume":"62","author":"M. Ciaccheri","year":"1989","unstructured":"Ciaccheri M, Castelli G, Cecchi F, et al.: Lack of correlation between intracavitary thrombus detected by cross-sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy. Br Heart J 1989, 62:26\u201329.","journal-title":"Br Heart J"},{"key":"26_CR17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0002-8703(91)90523-K","volume":"122","author":"D.S. Blondheim","year":"1991","unstructured":"Blondheim DS, Jacobs LE, Kotler MN, et al.: Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 1991, 122:763\u2013771.","journal-title":"Am Heart J"},{"key":"26_CR18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0002-8703(92)90757-M","volume":"123","author":"R.H. Falk","year":"1992","unstructured":"Falk RH, Foster E, Coats MH: Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J 1992, 123:136\u2013142.","journal-title":"Am Heart J"},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-8703(07)80021-4","volume":"126","author":"S.D. Katz","year":"1993","unstructured":"Katz SD, Marantz PR, Biasucci L, et al.: Low incidence of stroke in ambulatory patients with heart failure: a prospective study. Am Heart J 1993, 126:141\u2013146.","journal-title":"Am Heart J"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0002-8703(95)90286-4","volume":"129","author":"P.D. Natterson","year":"1995","unstructured":"Natterson PD, Stevenson WG, Saxon LA, et al.: Risk of arterial embolization in 224 patients awaiting cardiac transplantation. Am Heart J 1995, 129:564\u2013570.","journal-title":"Am Heart J"},{"key":"26_CR21","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/oxfordjournals.eurheartj.a015073","volume":"17","author":"G. Cioffie","year":"1996","unstructured":"Cioffie G, Pozzoli M, Forni G, et al.: Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients. Eur Heart J 1996, 17:1381\u20131389.","journal-title":"Eur Heart J"},{"key":"26_CR22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-0038-1657888","volume":"54","author":"P.A. Kyrle","year":"1985","unstructured":"Kyrle PA, Kominger C, Gossinger H, et al.: Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost 1985, 54:521\u2013523.","journal-title":"Thromb Haemost"},{"key":"26_CR23","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/01.STR.0000227121.34717.40","volume":"37","author":"A.G. Hays","year":"2006","unstructured":"Hays AG, Sacco RL, Rundek T, et al.: Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke 2006, 37:1715\u20131719.","journal-title":"Stroke"},{"key":"26_CR24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","volume":"160","author":"J.A. Heit","year":"2000","unstructured":"Heit JA, Silverstein MD, Mohr DN, et al.: Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000, 160:809\u2013815.","journal-title":"Arch Intern Med"},{"key":"26_CR25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0895-4356(00)00373-5","volume":"54","author":"M.D. Howell","year":"2001","unstructured":"Howell MD, Geraci JM, Knowlton AA: Congestive heart failure and outpatient risk of venous thromboembolism: a retrospective, case-control study. J Clin Epidemiol 2001, 54:810\u2013816.","journal-title":"J Clin Epidemiol"},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1001\/archinte.160.22.3415","volume":"160","author":"M.M. Samama","year":"2000","unstructured":"Samama MM: An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the SIRIUS study. Arch Intern Med 2000, 160:3415\u20133420.","journal-title":"Arch Intern Med"},{"issue":"supplIV","key":"26_CR27","first-page":"94","volume":"87","author":"W.B. Dunkman","year":"1993","unstructured":"Dunkman WB, Johnson GR, Carson PE, et al.: Incidence of thromboembolic events in congestive heart failure. Circulation 1993, 87(suppl IV):94\u2013101.","journal-title":"Circulation"},{"key":"26_CR28","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0735-1097(97)00019-3","volume":"29","author":"D.L. Dries","year":"1997","unstructured":"Dries DL, Rosenberg YD, Waclawiw MA, et al.: Ejection fraction and risk of thromboembolic events in patients with sinus rhythm: evidence of gender difference in the studies of left ventricular dysfunction trial. J Am Coll Cardiol 1997, 29:1074\u20131080.","journal-title":"J Am Coll Cardiol"},{"key":"26_CR29","doi-asserted-by":"crossref","unstructured":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators [no authors listed]. Lancet 1993, 342:821\u2013828.","DOI":"10.1016\/0140-6736(93)92693-N"},{"key":"26_CR30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJM199701233360403","volume":"336","author":"E. Loh","year":"1997","unstructured":"Loh E, Sutton MJ, Wun CC, et al.: Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997, 336:251\u2013257.","journal-title":"N Engl J Med"},{"key":"26_CR31","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/01.CIR.103.13.1746","volume":"103","author":"C.R. Gibbs","year":"2001","unstructured":"Gibbs CR, Blann AD, Watson RD, et al.: Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm. Circulation 2001, 103:1746\u20131751.","journal-title":"Circulation"},{"key":"26_CR32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-8703(94)90670-X","volume":"127","author":"E. Sbarouni","year":"1994","unstructured":"Sbarouni E, Bradshaw A, Andreotti F, et al.: Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am Heart J 1994, 127:607\u2013612.","journal-title":"Am Heart J"},{"key":"26_CR33","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1161\/01.CIR.0000143073.60937.50","volume":"110","author":"A.Y. Chong","year":"2004","unstructured":"Chong AY, Blann AD, Patel J, et al.: Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation 2004, 110:1794\u20131798.","journal-title":"Circulation"},{"key":"26_CR34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1067\/mhj.2003.189","volume":"145","author":"F.X. Kleber","year":"2003","unstructured":"Kleber FX, Witt C, Vogel G, et al.: Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J 2003, 145:614\u2013621.","journal-title":"Am Heart J"},{"key":"26_CR35","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","volume":"110","author":"A. Leizorovicz","year":"2004","unstructured":"Leizorovicz A, Cohen AT, Turpie AG, et al.: Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004, 110:874\u2013879.","journal-title":"Circulation"},{"key":"26_CR36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","volume":"332","author":"A.T. Cohen","year":"2006","unstructured":"Cohen AT, Davidson BL, Gallus AS, et al.: Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial. BMJ 2006, 332:325\u2013329.","journal-title":"BMJ"},{"key":"26_CR37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1056\/NEJM195002092420603","volume":"242","author":"W.P. Harvey","year":"1950","unstructured":"Harvey WP, Finch CA: Dicumarol prophylaxis of thromboembolic disease in congestive heart failure. N Engl J Med 1950, 242:208\u2013211.","journal-title":"N Engl J Med"},{"key":"26_CR38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0002-8703(50)90129-3","volume":"39","author":"G.M. Anderson","year":"1950","unstructured":"Anderson GM, Hull E: The effect of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure. Am Heart J 1950, 39:697\u2013702.","journal-title":"Am Heart J"},{"key":"26_CR39","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-37-5-867","volume":"37","author":"G.C. Griffiths","year":"1952","unstructured":"Griffiths GC, Stragnell R, Levinson DC, et al.: A study of the beneficial effects of anticoagulant therapy in congestive heart failure. Ann Intern Med 1952, 37:867\u2013887.","journal-title":"Ann Intern Med"},{"key":"26_CR40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0735-1097(98)00006-0","volume":"31","author":"A.S. Al-Khadra","year":"1998","unstructured":"Al-Khadra AS, Salem DN, Rand WM, et al.: Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. J Am Coll Cardiol 1998, 31:749\u2013753.","journal-title":"J Am Coll Cardiol"},{"key":"26_CR41","doi-asserted-by":"crossref","unstructured":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group [no authors listed]. N Engl J Med 1987, 316:1429\u20131435.","DOI":"10.1056\/NEJM198706043162301"},{"key":"26_CR42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1388-9842(02)00028-4","volume":"4","author":"M. Echemann","year":"2002","unstructured":"Echemann M, Alla F, Briancon S, et al.: Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study). Eur J Heart Fail 2002, 4:647\u2013654.","journal-title":"Eur J Heart Fail"},{"key":"26_CR43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","volume":"148","author":"J.G. Cleland","year":"2004","unstructured":"Cleland JG, Findlay I, Jafri S, et al.: The Warfarin\/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 2004, 148:157\u2013164.","journal-title":"Am Heart J"},{"key":"26_CR44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cardfail.2004.02.006","volume":"10","author":"B.M. Massie","year":"2004","unstructured":"Massie BM, Krol WF, Ammon SE, et al.: The Warfarin and Antiplatelet Therapy in Heart Failure trial(WATCH): rationale, design, and baseline patient characteristics. J Card Fail 2004, 10:101\u2013112.","journal-title":"J Card Fail"},{"key":"26_CR45","unstructured":"Massie BM, Krol WF, Ammon SE, et al.: Final results of the Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): a randomized comparison of warfarin, aspirin, and clopidogrel. Paper presented at the Annual Scientific Session of the American College of Cardiology. New Orleans, LA; March 7\u201310, 2004."},{"key":"26_CR46","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejheart.2006.02.012","volume":"8","author":"D.V. Cokkinos","year":"2006","unstructured":"Cokkinos DV, Haralabopoulos GC, Kostis JB, et al.: Efficacy of antithrom botic therapy in chronic heart failure: the HELAS study. Eur J Heart Fail 2006, 8:428\u2013432.","journal-title":"Eur J Heart Fail"},{"key":"26_CR47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cardfail.2005.07.007","volume":"12","author":"P. Pullicino","year":"2006","unstructured":"Pullicino P, Thompson JL, Barton B, et al.: Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design. J Card Fail 2006, 12:39\u201346.","journal-title":"J Card Fail"},{"key":"26_CR48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0735-1097(97)00502-0","volume":"31","author":"A.S. Al-Khadra","year":"1998","unstructured":"Al-Khadra AS, Salem DN, Rand WM, et al.: Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. J Am Coll Cardiol 1998, 31:419\u2013425.","journal-title":"J Am Coll Cardiol"},{"key":"26_CR49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9149(96)00696-0","volume":"15","author":"K.N. Nguyen","year":"1997","unstructured":"Nguyen KN, Aursnes I, Kjekshus J: Interaction between enalapril and aspirin on mortality after acute myocardial infarction. Subgroup Anal Cooperative New Scand Enalapril Survival Study II (CONSENSUS II). Am J Cardiol 1997, 15:115\u2013119.","journal-title":"Am J Cardiol"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-007-0026-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-007-0026-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-007-0026-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T04:24:34Z","timestamp":1587788674000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-007-0026-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,9]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s11936-007-0026-1","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,9]]}}}